Rellon, Baby Boy .

HRN: 27-15-78  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2025
CEFOTAXIME 500MG (VIAL)
06/01/2025
06/07/2025
IV
22 Mg
Q12H
RDS; NEC
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines